Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report)’s stock price fell 0.9% during trading on Thursday . The company traded as low as C$3.10 and last traded at C$3.16. 34,188 shares traded hands during mid-day trading, a decline of 21% from the average session volume of 43,251 shares. The stock had previously closed at C$3.19.
Medexus Pharmaceuticals Stock Performance
The stock has a fifty day moving average price of C$2.90 and a 200-day moving average price of C$2.84. The firm has a market capitalization of C$102.07 million, a PE ratio of -158.00 and a beta of 0.79.
About Medexus Pharmaceuticals
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc is a leading specialty pharmaceutical company with a strong North American commercial platform. It is focused on the therapeutic areas of auto-immune disease and pediatrics. The leading products are Rasuvo and Metoject, a unique formulation of methotrexate to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an innovative allergy medication with a unique mode of action.
Read More
- Five stocks we like better than Medexus Pharmaceuticals
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
